• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 小鼠适应性选择毒力突变,导致 TNF 驱动的与人类相关的年龄依赖性严重疾病。

SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates.

机构信息

The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.

Department of Medical Biology, University of Melbourne, Melbourne, VIC 3052, Australia.

出版信息

Proc Natl Acad Sci U S A. 2023 Aug 8;120(32):e2301689120. doi: 10.1073/pnas.2301689120. Epub 2023 Jul 31.

DOI:10.1073/pnas.2301689120
PMID:37523564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10410703/
Abstract

The diversity of COVID-19 disease in otherwise healthy people, from seemingly asymptomatic infection to severe life-threatening disease, is not clearly understood. We passaged a naturally occurring near-ancestral SARS-CoV-2 variant, capable of infecting wild-type mice, and identified viral genomic mutations coinciding with the acquisition of severe disease in young adult mice and lethality in aged animals. Transcriptomic analysis of lung tissues from mice with severe disease elucidated a host antiviral response dominated mainly by interferon and IL-6 pathway activation in young mice, while in aged animals, a fatal outcome was dominated by TNF and TGF-β signaling. Congruent with our pathway analysis, we showed that young TNF-deficient mice had mild disease compared to controls and aged TNF-deficient animals were more likely to survive infection. Emerging clinical correlates of disease are consistent with our preclinical studies, and our model may provide value in defining aberrant host responses that are causative of severe COVID-19.

摘要

在原本健康的人群中,COVID-19 疾病的表现形式多种多样,从看似无症状感染到严重危及生命的疾病,其发病机制尚不清楚。我们对一种自然发生的接近原始 SARS-CoV-2 变体进行了传代培养,该变体能够感染野生型小鼠,并发现了与年轻成年小鼠发生严重疾病以及老年动物致死性相一致的病毒基因组突变。对患有严重疾病的小鼠肺部组织的转录组分析阐明了一种抗病毒反应,该反应主要由干扰素和 IL-6 通路激活所主导,而在老年动物中,致命结局则主要由 TNF 和 TGF-β 信号转导所主导。与我们的通路分析一致,我们发现年轻的 TNF 缺陷型小鼠与对照相比疾病较轻,而老年 TNF 缺陷型动物更有可能在感染后存活。疾病的新兴临床相关性与我们的临床前研究一致,我们的模型可能有助于确定导致严重 COVID-19 的异常宿主反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d496/10410703/bcdd1b8c75e1/pnas.2301689120fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d496/10410703/336f86895653/pnas.2301689120fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d496/10410703/58d6923bbb19/pnas.2301689120fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d496/10410703/2e8e153f49a8/pnas.2301689120fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d496/10410703/bcdd1b8c75e1/pnas.2301689120fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d496/10410703/336f86895653/pnas.2301689120fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d496/10410703/58d6923bbb19/pnas.2301689120fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d496/10410703/2e8e153f49a8/pnas.2301689120fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d496/10410703/bcdd1b8c75e1/pnas.2301689120fig04.jpg

相似文献

1
SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates.SARS-CoV-2 小鼠适应性选择毒力突变,导致 TNF 驱动的与人类相关的年龄依赖性严重疾病。
Proc Natl Acad Sci U S A. 2023 Aug 8;120(32):e2301689120. doi: 10.1073/pnas.2301689120. Epub 2023 Jul 31.
2
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.SARS-CoV-2 引起人类 ACE2 基因敲入小鼠肺部感染但不引起严重疾病。
J Virol. 2022 Jan 12;96(1):e0151121. doi: 10.1128/JVI.01511-21. Epub 2021 Oct 20.
3
B.1.351 SARS-CoV-2 Variant Exhibits Higher Virulence but Less Viral Shedding than That of the Ancestral Strain in Young Nonhuman Primates.B.1.351 型 SARS-CoV-2 变异株在年轻非人类灵长类动物中的毒力高于原始株,但病毒脱落量较少。
Microbiol Spectr. 2022 Oct 26;10(5):e0226322. doi: 10.1128/spectrum.02263-22. Epub 2022 Sep 7.
4
Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19.两种异质性致死性适应小鼠的 SARS-CoV-2 变异株的特征,再现了人类 COVID-19 的代表性方面。
Front Immunol. 2022 Feb 7;13:821664. doi: 10.3389/fimmu.2022.821664. eCollection 2022.
5
SARS-CoV-2 Variants of Concern Infect the Respiratory Tract and Induce Inflammatory Response in Wild-Type Laboratory Mice.SARS-CoV-2 关切变异株感染呼吸道并诱导野生型实验小鼠的炎症反应。
Viruses. 2021 Dec 24;14(1):27. doi: 10.3390/v14010027.
6
Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.小胶质细胞在 K18-Human ACE2 转基因小鼠中枢神经系统感染后并不限制 SARS-CoV-2 的复制。
J Virol. 2022 Feb 23;96(4):e0196921. doi: 10.1128/jvi.01969-21. Epub 2021 Dec 22.
7
Dysregulated early transcriptional signatures linked to mast cell and interferon responses are implicated in COVID-19 severity.失调的早期转录特征与肥大细胞和干扰素反应有关,这些特征与 COVID-19 的严重程度有关。
Front Immunol. 2023 May 16;14:1166574. doi: 10.3389/fimmu.2023.1166574. eCollection 2023.
8
Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease.严重急性呼吸综合征冠状病毒在人类疾病的年轻和老年小鼠模型中发病机制和毒力的分子决定因素。
J Virol. 2012 Jan;86(2):884-97. doi: 10.1128/JVI.05957-11. Epub 2011 Nov 9.
9
The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.K18-Human ACE2 转基因小鼠模型对 SARS-CoV-2 病毒感染剂量的反应可重现非重症和重症 COVID-19。
J Virol. 2022 Jan 12;96(1):e0096421. doi: 10.1128/JVI.00964-21. Epub 2021 Oct 20.
10
Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.传染性克隆产生的 SARS-CoV-2 可导致感染 K18-Human ACE2 小鼠发生严重肺部疾病。
mBio. 2021 Apr 20;12(2):e00819-21. doi: 10.1128/mBio.00819-21.

引用本文的文献

1
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID.一种新型的木瓜蛋白酶样蛋白酶(PLpro)抑制剂在新冠长期症状的临床前模型中改善了治疗结果。
Nat Commun. 2025 Apr 3;16(1):2900. doi: 10.1038/s41467-025-57905-4.
2
Targeted labeling and depletion of alveolar macrophages using VeDTR mouse technology.使用VeDTR小鼠技术对肺泡巨噬细胞进行靶向标记和清除。
iScience. 2025 Feb 9;28(3):111975. doi: 10.1016/j.isci.2025.111975. eCollection 2025 Mar 21.
3
Tuning the tropism and infectivity of SARS-CoV-2 virus-like particles for mRNA delivery.

本文引用的文献

1
Systematic review with meta-analysis: COVID-19 outcomes in patients receiving anti-TNF treatments.系统评价与荟萃分析:接受抗 TNF 治疗的患者的 COVID-19 结局。
Aliment Pharmacol Ther. 2022 Jan;55(2):154-167. doi: 10.1111/apt.16717. Epub 2021 Dec 8.
2
Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNFα-antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure.CXCL-10(IP-10)的快速且持续下降预示着重度和危重型COVID-19呼吸衰竭住院患者接受肿瘤坏死因子α拮抗剂治疗后的临床结局。
J Clin Transl Sci. 2021 Jun 25;5(1):e146. doi: 10.1017/cts.2021.805. eCollection 2021.
3
调整用于mRNA递送的SARS-CoV-2病毒样颗粒的嗜性和感染性。
Nucleic Acids Res. 2025 Feb 27;53(5). doi: 10.1093/nar/gkaf133.
4
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling.白细胞介素-1β独立于炎性小体和细胞焦亡信号传导驱动新冠病毒诱导的疾病。
Cell Death Differ. 2025 Feb 28. doi: 10.1038/s41418-025-01459-x.
5
Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice.喷射注射编码严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白受体结合域(RBD)的裸露信使核糖核酸(mRNA)可在小鼠体内诱导高水平的特异性免疫反应。
Vaccines (Basel). 2025 Jan 13;13(1):65. doi: 10.3390/vaccines13010065.
6
TNF-α exacerbates SARS-CoV-2 infection by stimulating CXCL1 production from macrophages.肿瘤坏死因子-α通过刺激巨噬细胞产生CXCL1来加重新型冠状病毒2型感染。
PLoS Pathog. 2024 Dec 9;20(12):e1012776. doi: 10.1371/journal.ppat.1012776. eCollection 2024 Dec.
7
ACE2, From the Kidney to SARS-CoV-2: Donald Seldin Award Lecture 2023.从肾脏到新型冠状病毒2:2023年唐纳德·塞尔丁奖讲座。 (注:ACE2一般指血管紧张素转换酶2,这里结合全文可能是与新型冠状病毒2相关的内容,但原文中未明确展开解释ACE2具体在这个语境下的详细含义,直接按字面呈现其英文缩写形式。)
Hypertension. 2025 Feb;82(2):166-180. doi: 10.1161/HYPERTENSIONAHA.124.22064. Epub 2024 Dec 3.
8
Rapid Development of Small Rodent Animal Models for Infectious Disease Research Through Vectorized Receptor Molecule Expression.通过载体化受体分子表达快速开发传染病研究用小型啮齿类动物模型。
Viruses. 2024 Nov 19;16(11):1794. doi: 10.3390/v16111794.
9
Investigating the impact of severe maternal SARS-CoV-2 infection on infant DNA methylation and neurodevelopment.调查孕产妇严重感染新冠病毒对婴儿DNA甲基化和神经发育的影响。
Mol Psychiatry. 2025 May;30(5):1976-1984. doi: 10.1038/s41380-024-02808-x. Epub 2024 Oct 30.
10
CD4 and CD8 T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment.CD4 和 CD8 T 细胞对于防止 SARS-CoV-2 在鼻腔内持续存在是必需的。
Sci Adv. 2024 Aug 23;10(34):eadp2636. doi: 10.1126/sciadv.adp2636.
SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的N501Y变异株及其在小鼠中的潜在传播
Cell Death Differ. 2021 Oct;28(10):2840-2842. doi: 10.1038/s41418-021-00846-4. Epub 2021 Aug 13.
4
N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding.N501Y突变通过增强受体结合赋予SARS-CoV-2跨物种传播至小鼠的能力。
Signal Transduct Target Ther. 2021 Jul 27;6(1):284. doi: 10.1038/s41392-021-00704-2.
5
Genomics-informed responses in the elimination of COVID-19 in Victoria, Australia: an observational, genomic epidemiological study.澳大利亚维多利亚州利用基因组学信息消除 COVID-19 的反应:一项观察性、基因组流行病学研究。
Lancet Public Health. 2021 Aug;6(8):e547-e556. doi: 10.1016/S2468-2667(21)00133-X. Epub 2021 Jul 10.
6
Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment.越来越多的证据表明,在新冠病毒病治疗中,抗TNF治疗需要优先进行试验。
Lancet Rheumatol. 2020 Nov;2(11):e653-e655. doi: 10.1016/S2665-9913(20)30309-X. Epub 2020 Sep 5.
7
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.经鼻腔接种 SARS-CoV-2 后 K18-hACE2 小鼠的神经侵袭和脑炎。
Viruses. 2021 Jan 19;13(1):132. doi: 10.3390/v13010132.
8
SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis.SARS-CoV-2 通过网格蛋白介导的内吞作用感染细胞。
J Biol Chem. 2021 Jan-Jun;296:100306. doi: 10.1016/j.jbc.2021.100306. Epub 2021 Jan 19.
9
Interrelations between COVID-19 and other disorders.新型冠状病毒肺炎与其他疾病的相互关系。
Clin Immunol. 2021 Mar;224:108651. doi: 10.1016/j.clim.2020.108651. Epub 2020 Dec 14.
10
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.TNF-α 和 IFN-γ 的协同作用可引发 SARS-CoV-2 感染和细胞因子休克综合征中的炎症细胞死亡、组织损伤和死亡。
Cell. 2021 Jan 7;184(1):149-168.e17. doi: 10.1016/j.cell.2020.11.025. Epub 2020 Nov 19.